Park Square Financial Group, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Park Square Financial Group, LLC

  • $138 Billion
  • Q2 2025

A detailed history of Park Square Financial Group, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Park Square Financial Group, LLC holds 789 shares of XBI stock, worth $85,140. This represents 0.05% of its overall portfolio holdings.

Number of Shares
789
Previous 786 0.38%
Holding current value
$85,140
Previous $63.7 Million 2.65%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$69.8 - $85.28 $209 - $255
3 Added 0.38%
789 $65.4 Million
Q1 2025

Apr 30, 2025
SELL
$81.1 - $94.7 $23,924 - $27,936
-295 Reduced 27.29%
786 $63.7 Million
Q4 2024

Feb 28, 2025
BUY
$89.81 - $104.0 $97,084 - $112,424
1,081 New
1,081 $97.3 Million

Others Institutions Holding XBI

# of Institutions
819
Shares Held
111M
Call Options Held
22.6M
Put Options Held
28.8M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Park Square Financial Group, LLC Portfolio

Follow Park Square Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Square Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Square Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email